NewLink Genetics Corporation (NLNK)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
10.22+0.18 (+1.79%)
At close: 4:00 PM EDT
People also watch:
TKMRCMRXSRPTCLVSCLDX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open10.02
Prev Close10.04
Bid9.67 x 500
Ask10.47 x 200
Day's Range10.02 - 10.36
52wk Range9.23 - 55.47
1y Target EstN/A
Market Cap296.07M
P/E Ratio (ttm)-3.15
Beta1.53
Volume193,307
Avg Vol (3m)369,461
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube9 days ago

    ETF’s with exposure to NewLink Genetics Corp. : August 22, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to NewLink Genetics Corp. Here are 5 ETF’s with the largest exposure to NLNK-US. Comparing the performance and risk of NewLink Genetics Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube23 days ago

    ETF’s with exposure to NewLink Genetics Corp. : August 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to NewLink Genetics Corp. Here are 5 ETF’s with the largest exposure to NLNK-US. Comparing the performance and risk of NewLink Genetics Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
    Capital Cube26 days ago

    NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016

    Categories: Yahoo Finance Click here to see latest analysis NewLink Genetics Corp. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of NewLink Genetics Corp. – Eli Lilly and Company, Threshold Pharmaceuticals, Inc., Pfizer Inc., Sarepta Therapeutics, Inc., Johnson & Johnson and Bristol-Myers Squibb Company (LLY-US, THLD-US, PFE-US, ... Read more (Read more...)